Prelude Therapeutics Stock Price History

PRLD Stock  USD 0.74  0  0.41%   
Below is the normalized historical share price chart for Prelude Therapeutics extending back to September 25, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Prelude Therapeutics stands at 0.74, as last reported on the 21st of March, with the highest price reaching 0.74 and the lowest price hitting 0.74 during the day.
IPO Date
25th of September 2020
200 Day MA
2.5398
50 Day MA
0.9513
Beta
1.42
 
Covid
If you're considering investing in Prelude Stock, it is important to understand the factors that can impact its price. Prelude Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.11, which implies the firm had a -0.11 % return per unit of risk over the last 3 months. Prelude Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Prelude Therapeutics' Coefficient Of Variation of (21,296), risk adjusted performance of 0.0048, and Variance of 73.0 to confirm the risk estimate we provide.
  
At present, Prelude Therapeutics' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. . At present, Prelude Therapeutics' Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 0.77, whereas Price Earnings Ratio is forecasted to decline to (0.79). Prelude Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1096

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsPRLD

Estimated Market Risk

 6.26
  actual daily
55
55% of assets are less volatile

Expected Return

 -0.69
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.11
  actual daily
0
Most of other assets perform better
Based on monthly moving average Prelude Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Prelude Therapeutics by adding Prelude Therapeutics to a well-diversified portfolio.
Price Book
0.3093
Enterprise Value Ebitda
(0.54)
Price Sales
5.8086
Shares Float
17.7 M
Wall Street Target Price
3.3333

Prelude Therapeutics Stock Price History Chart

There are several ways to analyze Prelude Stock price data. The simplest method is using a basic Prelude candlestick price chart, which shows Prelude Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceDecember 26, 20241.4
Lowest PriceMarch 11, 20250.66

Prelude Therapeutics March 21, 2025 Stock Price Synopsis

Various analyses of Prelude Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Prelude Stock. It can be used to describe the percentage change in the price of Prelude Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Prelude Stock.
Prelude Therapeutics Price Rate Of Daily Change 1.00 

Prelude Therapeutics March 21, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Prelude Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Prelude Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Prelude Stock and then apply it to test your longer-term investment strategies against Prelude.

Prelude Stock Price History Data

The price series of Prelude Therapeutics for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 0.74 with a coefficient of variation of 20.67. The price distribution for the period has arithmetic mean of 0.99. The median price for the last 90 days is 1.01.
OpenHighLowCloseVolume
03/21/2025
 0.74  0.74  0.74  0.74 
03/21/2025
 0.74  0.80  0.70  0.74 
03/19/2025 0.71  0.80  0.70  0.74  84,188 
03/18/2025 0.75  0.75  0.70  0.71  64,231 
03/17/2025 0.75  0.80  0.74  0.75  186,646 
03/14/2025 0.75  0.79  0.74  0.74  301,278 
03/13/2025 0.70  0.80  0.68  0.71  165,353 
03/12/2025 0.71  0.76  0.69  0.70  259,318 
03/11/2025 0.67  0.86  0.66  0.66  188,994 
03/10/2025 0.72  0.76  0.67  0.67  203,320 
03/07/2025 0.71  0.76  0.71  0.74  81,669 
03/06/2025 0.74  0.76  0.71  0.71  73,440 
03/05/2025 0.75  0.77  0.70  0.76  86,427 
03/04/2025 0.68  0.75  0.67  0.74  110,780 
03/03/2025 0.74  0.77  0.67  0.68  254,457 
02/28/2025 0.75  0.78  0.73  0.76  174,754 
02/27/2025 0.81  0.83  0.74  0.75  243,909 
02/26/2025 0.81  0.84  0.81  0.81  146,825 
02/25/2025 0.83  0.85  0.81  0.81  183,642 
02/24/2025 0.88  0.91  0.83  0.83  100,308 
02/21/2025 0.93  0.93  0.87  0.87  161,152 
02/20/2025 0.91  0.95  0.87  0.90  167,023 
02/19/2025 0.95  0.98  0.89  0.90  183,009 
02/18/2025 0.99  0.99  0.93  0.95  202,770 
02/14/2025 0.94  1.01  0.94  0.97  169,677 
02/13/2025 0.94  0.96  0.91  0.95  148,455 
02/12/2025 0.91  0.97  0.90  0.91  211,126 
02/11/2025 1.08  1.08  0.92  0.92  283,814 
02/10/2025 1.04  1.09  0.98  1.09  691,077 
02/07/2025 1.10  1.13  1.00  1.01  262,964 
02/06/2025 1.17  1.19  1.10  1.11  106,199 
02/05/2025 1.12  1.19  1.10  1.17  218,966 
02/04/2025 1.11  1.14  1.09  1.11  74,517 
02/03/2025 1.10  1.13  1.07  1.11  65,165 
01/31/2025 1.20  1.20  1.10  1.10  268,239 
01/30/2025 1.15  1.22  1.10  1.19  141,030 
01/29/2025 1.13  1.20  1.08  1.15  156,901 
01/28/2025 1.12  1.14  1.06  1.14  129,931 
01/27/2025 1.22  1.22  1.12  1.13  125,985 
01/24/2025 1.15  1.27  1.13  1.22  240,787 
01/23/2025 1.13  1.18  1.05  1.14  171,478 
01/22/2025 1.22  1.31  1.15  1.17  333,949 
01/21/2025 1.06  1.30  1.05  1.22  901,100 
01/17/2025 1.00  1.06  0.99  1.05  147,785 
01/16/2025 1.06  1.06  0.99  1.02  232,968 
01/15/2025 1.02  1.05  1.01  1.03  83,259 
01/14/2025 1.03  1.07  1.00  1.02  137,794 
01/13/2025 1.08  1.08  0.98  1.03  397,642 
01/10/2025 1.13  1.16  1.03  1.06  327,253 
01/08/2025 1.21  1.26  1.13  1.14  243,142 
01/07/2025 1.31  1.33  1.15  1.21  280,983 
01/06/2025 1.38  1.43  1.29  1.33  271,312 
01/03/2025 1.40  1.41  1.30  1.39  455,999 
01/02/2025 1.28  1.29  1.21  1.25  313,373 
12/31/2024 1.25  1.34  1.17  1.27  616,198 
12/30/2024 1.34  1.38  1.12  1.21  919,036 
12/27/2024 1.41  1.48  1.33  1.34  442,745 
12/26/2024 1.30  1.41  1.27  1.40  430,455 
12/24/2024 1.22  1.24  1.14  1.19  218,009 
12/23/2024 1.31  1.59  1.15  1.24  1,433,548 
12/20/2024 0.94  1.45  0.94  1.30  4,441,321 

About Prelude Therapeutics Stock history

Prelude Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Prelude is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Prelude Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Prelude Therapeutics stock prices may prove useful in developing a viable investing in Prelude Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding75.8 M53.3 M
Net Loss-103.9 M-109.1 M

Prelude Therapeutics Quarterly Net Working Capital

110.25 Million

Prelude Therapeutics Stock Technical Analysis

Prelude Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Prelude Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Prelude Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Holdings Now

   

Portfolio Holdings

Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
All  Next Launch Module

Prelude Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Prelude Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Prelude Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Prelude to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Prelude Stock analysis

When running Prelude Therapeutics' price analysis, check to measure Prelude Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prelude Therapeutics is operating at the current time. Most of Prelude Therapeutics' value examination focuses on studying past and present price action to predict the probability of Prelude Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prelude Therapeutics' price. Additionally, you may evaluate how the addition of Prelude Therapeutics to your portfolios can decrease your overall portfolio volatility.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities